Legal & General Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,390
| Closed | -$17K | – | 3712 |
|
|
2021
Q1 | $17K | Buy |
3,390
+868
| +34% | +$4.35K | ﹤0.01% | 3198 |
|
|
2020
Q4 | $32K | Hold |
2,522
| – | – | ﹤0.01% | 2934 |
|
|
2020
Q3 | $25K | Sell |
2,522
-1,109
| -31% | -$11K | ﹤0.01% | 2917 |
|
|
2020
Q2 | $36K | Buy |
3,631
+332
| +10% | +$3.29K | ﹤0.01% | 2828 |
|
|
2020
Q1 | $29K | Sell |
3,299
-236
| -7% | -$2.08K | ﹤0.01% | 2780 |
|
|
2019
Q4 | $33K | Hold |
3,535
| – | – | ﹤0.01% | 3010 |
|
|
2019
Q3 | $21K | Hold |
3,535
| – | – | ﹤0.01% | 3122 |
|
|
2019
Q2 | $42K | Hold |
3,535
| – | – | ﹤0.01% | 2848 |
|
|
2019
Q1 | $43K | Buy |
3,535
+358
| +11% | +$4.36K | ﹤0.01% | 2764 |
|
|
2018
Q4 | $40K | Hold |
3,177
| – | – | ﹤0.01% | 2780 |
|
|
2018
Q3 | $47K | Hold |
3,177
| – | – | ﹤0.01% | 2801 |
|
|
2018
Q2 | $53K | Buy |
3,177
+5
| +0.2% | +$83 | ﹤0.01% | 2723 |
|
|
2018
Q1 | $73K | Sell |
3,172
-1,380
| -30% | -$31.8K | ﹤0.01% | 2588 |
|
|
2017
Q4 | $118K | Sell |
4,552
-862
| -16% | -$22.3K | ﹤0.01% | 2506 |
|
|
2017
Q3 | $79K | Buy |
5,414
+985
| +22% | +$14.4K | ﹤0.01% | 2756 |
|
|
2017
Q2 | $62K | Hold |
4,429
| – | – | ﹤0.01% | 2844 |
|
|
2017
Q1 | $74K | Sell |
4,429
-739
| -14% | -$12.3K | ﹤0.01% | 2714 |
|
|
2016
Q4 | $53K | Buy |
5,168
+3,033
| +142% | +$31.1K | ﹤0.01% | 2877 |
|
|
2016
Q3 | $21K | Hold |
2,135
| – | – | ﹤0.01% | 2808 |
|
|
2016
Q2 | $24K | Hold |
2,135
| – | – | ﹤0.01% | 2810 |
|
|
2016
Q1 | $29K | Buy |
+2,135
| New | +$29K | ﹤0.01% | 2595 |
|